A study funded by the National Institute Child Health and Human Development shows that anticholinergic drugs and onabotulinumtoxinA injections produce comparable results in women with urgency urinary incontinence. Choice of therapy, say the researchers, should take into consideration route of administration and adverse effect profiles.
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More